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Abstract
Background: Limb lengthening with external fixation is performed to treat patients with leg length discrepancy
or short stature. Although the procedure has a high rate of success, one potential drawback from limb lengthening
is the amount of time spent in the fixation device while regenerate bone consolidates. Although some studies have
assessed different treatment modalities, there has not been a study that has systematically evaluated whether low
intensity pulsed ultrasound (LIPUS) or pulsed electromagnetic fields (PEMF) have significant effects on regenerate
bone growth. The purpose of this study was to evaluate these two non-pharmacological treatment options to
stimulate regenerate bone, and to assess whether they affect the treatment time in limb lengthening.
Methods: Utilizing the electronic databases Medline, Embase and Ovid, we performed a literature search for studies
describing the application of LIPUS or PEMF following limb lengthening. With the aid of a statistical software
package, Forest-Plots were generated to compare the differences in bone healing index with and without the
use of regenerate bone stimulation.
Results: A total of 7 studies assessed these two bone stimulation modalities in a cohort of 153 patients. Overall, the
mean healing index was 11.7 days/cm faster when using bone stimulation that in the comparison cohorts (33.7 vs
45.4 day, standardized mean difference of 1.16; p = 0.003).
Conclusion: Amongst the drawbacks from limb lengthening is the relatively high rate of non- and delayed-union.
Several methods, both pharmacological and non-pharmacological, have been investigated for their potential to
stimulate the growth of regenerate bone. After systematically evaluating the limited and heterogeneous current
literature, we found that LIPUS and PEMF both decreased the time for bone healing (healing index in days/cm) of
the newly formed regenerate bone in an adequately selected cohort of patients that underwent limb lengthening.
However, a high number of complications should be noted, which could be attributed to the lengthening procedure
or to the additional bone stimulation.
PROSPERO registration number: CRD42016039024
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Background
Leg length discrepancy and short stature have multifac-
torial etiologies that may include congenital, develop-
mental, infectious, or posttraumatic. Limb lengthening is
an acceptable option to manage patients with these con-
ditions [1–5]. First described by Alessandro Codivilla in
the early 20th century [6], this procedure gained popu-
larity following the work of Gavriil Ilizarov and his
development of the external fixation device [7]. Ad-
vances in the field since then have led to a wider array
of methods with which to lengthen bone. Currently,
limb lengthening can be achieved by a variety of circular
and unilateral external fixation devices, lengthening over
nails (LON), and most recently lengthening with intra-
medullary telescoping rods [8–11]. Each technique car-
ries with it the potential for significant complications
[12–14]; many risk factors have been identified [15].
All methods of limb lengthening rely on the process of
distraction osteogenesis (DO), whereby an osteotomy is
performed and the bone ends are gradually displaced
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apart to facilitate the growth of regenerate bone [16–19].
Several factors may influence the rate at which bone re-
generates; distraction rate and bone quality may be the
most important [19–23]. Although a successful procedure,
problems associated with the growth of the regenerate
bone have been commonly described. These difficulties
may include premature consolidation, but also slow regen-
erate bone formation, delayed mineralization, or non-
union, which may contribute to the high rates of patient
morbidity seen in limb lengthening procedures [24]. Many
options, both pharmacological and non-pharmacological,
have been explored to enhance the rate of growth of
regenerate bone in humans and animals [25–29]. Within
the non-pharmacological alternatives, studies have de-
scribed the use of low intensity pulsed ultrasound (LIPUS)
as well as pulsed electromagnetic fields (PEMF) during
DO to enhance bone regeneration in animals [30–35].
Studies have demonstrated that LIPUS and PEMF stimu-
late many different cell types involved in bone healing,
including osteoblasts, osteoclasts, chondrocytes, and mes-
enchymal cells [36]. In addition, these methods of stimula-
tion have also been shown to increase the expression of
numerous genes (including IGF and TGF-β), the size of
the chondrocyte population, the synthesis of extracellular
matrix, and the rate of osteoblast differentiation [37–39].
While previous studies have attempted to assess the
efficacy of these alternatives in humans [40–46], there
has not been a study that has systematically evaluated
the success of LIPUS and PEMF in stimulating the re-
generate bone growth and improving patient outcomes.
Therefore, the purposes of this study were: (1) to deter-
mine the efficacy of these two non-pharmacological
alternatives utilized to stimulate regenerate bone healing
and (2) to establish the success rate of these alternatives
in decreasing treatment time and reducing the complica-
tions during limb lengthening.
Methods
We performed a systematic literature search to deter-
mine the possible alternatives to stimulate regenerate
bone healing. This was performed utilizing the preferred
reporting items for systematic review and meta-analysis
protocols (PRISMA) guidelines [47]. The electronic da-
tabases Medline, Embase and Ovid were queried to find
all relevant studies published in literature until July
2015. We utilized the search strings “limb lengthening,”
“distraction osteogenesis,” “bone transport,” or ”regener-
ate bone,” which yielded a total of 16372 results. Exclud-
ing non-human studies returned 10384 publications.
Further limiting the search string to studies written only
in English returned 9044 studies.
The titles and abstracts of these studies were then
carefully reviewed utilizing specific inclusion and exclu-
sion criteria. We specifically included studies evaluating
the use of LIPUS or PEMF to stimulate the regenerate
bone formation in limb lengthening patients. Single case
reports, review studies, and literature involving maxillary
or mandibular DO and craniofacial or maxillofacial sur-
gery were excluded. After applying these inclusion and
exclusion criteria, 7 studies were determined to be rele-
vant. The citations for these studies were cross-
referenced; however, no additional relevant studies were
found (Fig. 1).
The entire process was performed by one of the
authors (JJJ) and then fully repeated by another (AVV),
blinded from the previously performed search to ensure
all pertinent studies were included. We searched for spe-
cific endpoints within each study, which included age,
bone (humerus, tibia, or femur) lengthened, average dis-
traction distance, healing index, bone mineral density,
and indication for bone lengthening. The information
obtained from the literature review was logged into an
electronic spreadsheet (Microsoft Excel, Microsoft
Office, Redmond, Washington). Then, utilizing a Ran-
dom Model Effects, Forest-Plots were obtained to com-
pare the differences in bone healing index with and
without the use of a bone stimulator. This was per-
formed with the aid of statistical software (MedCalc,
MedCalc Software version 15.2, Ostend, Belgium). This
study was performed without external funding.
Results
The seven studies included in our final analysis evalu-
ated a total of 192 cases of limb lengthening and aver-
aged 27 limbs lengthened per study [40–46]. One
hundred fifty-three patients comprised of 118 males and
35 females with a mean weighted age of 26 years (range
of means 8 to 39 years) underwent limb lengthening
procedures. Thirty-nine of these patients underwent
bilateral, symmetrical lengthening with 30 patients re-
ceiving PEMF on one of the lengthened limbs, 7 receiv-
ing LIPUS bilaterally, and 2 patients in the control
group. Across all studies included in the analysis, 155
tibiae, 25 femora, and 12 humeri had undergone the
index procedure (Table 1).
A total of 103 limbs were stimulated; of these, 63 were
stimulated with LIPUS and 40 with PEMF. The mean
amount of limbs stimulated per study was 15. Most
studies applied LIPUS or PEMF concurrently during the
distraction phase, with the exceptions of the studies by
El-Mowafi and Mohsen [41] (LIPUS initiated one day
after cessation of distraction) and Gebauer and Correll
[42] (LIPUS initiated if the calcification of the newly
formed bone did not improve for at least 3 months).
The mean distraction distance in the treatment cohort
was 8.1 cm (range of means 6.1 to 11.3 cm). For those
studies reporting, the mean healing index for the treat-
ment cohort was 33.7 days/cm ranging from 30 to
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39 days/cm (Table 2). A total of 89 limbs with an aver-
age of 15 limbs per study underwent lengthening but
were not stimulated. The mean distraction distance in
the control cohorts was 8.2 cm (range of means 6.1 to
11.3 cm). A mean healing index of 45.4 days/cm ranging
from 44 to 48 days/cm was found in those studies that
reported the parameter (Table 2).
Of the 141 patients described in these studies, 70 were
treated with a circular external fixation device, 64 were
treated with a monolateral external fixator, and 7 were
16372 records identified through database 
searching
10384 records retrieved after excluding non-
human studies
No additional studies identified through 
cross-referencing
6707 records retrieved after excluding 
studies on bones of the skull or face
(11) – Pharmacological studies
(21) - Reviews
(1) – Case study
(5) – Biochemical studies 
(6) – Other 
Excluded Studies:
7 studies included in final analysis
9044 records retrieved after excluding non-
English studies
Fig. 1 Flowchart of search methodology and inclusion/exclusion criteria
Table 1 Study demographics
Authors, Year Number of
Patients
Number of Limbs Mean Age in Years
(Range)
Tibia (%) Femur (%) Humerus (%) Modality Used
Salem and Schmelz, 2014 [43] 21 21 31 (− to -) 100 % 0 % 0 % LIPUS
El-Mowafi and Mohsen, 2005 [41] 20 20 35 (18 to 45) 100 % 0 % 0 % LIPUS
Dudda et al., 2011 [40] 36 36 39 (16 to 69) 100 % 0 % 0 % LIPUS
Gebauer and Correll, 2005 [42] 13 17 7.85 (− to -) 94 % 6 % 0 % LIPUS
Gonzalez et al., 2005 [44] 30 60 11 (− to -) 47 % 33 % 20 % PEMF
Eyres et al., 1996 [45] 13 18 17.9 (11 to 19) 78 % 22 % 0 % PEMF
Gold and Wasserman, 2005 [46] 20 20 34 (18 to 50) 100 % 0 % 0 % LIPUS
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treated with hybrid fixation (unilateral and circular ring
fixators) [48]. In terms of the indication for the proced-
ure, there were 40 posttraumatic leg length discrepancies
(LLD), 14 congenital LLD, 38 symmetric growth restric-
tions (i.e. achondroplasia), and 5 had unclassified indica-
tions (Table 3). Additionally, eight bone transports were
included in our study. Only two studies described spe-
cific complications: El-Mowafi and Mohsen [41] re-
ported 5 complications, which were 1 case of delayed
union in the treatment group, 4 cases of delayed union
in the control group, and 1 failure to consolidate in the
control group. Dudda et al. [40] reported 6
complications, which were 1 amputation in both the
treatment and control groups, 1 pseudoarthrosis in the
treatment group, and 3 pseudoarthroses in the control
group (Table 3). All of the other studies evaluated failed
to mention complication rates.
Of the seven studies, only four studies provided
detailed information regarding the differences in the
healing index between the stimulated (treatment) and
non-stimulated (control) cohorts. We found that the
mean healing index was 11.7 days/cm faster when using
bone stimulation that in the comparison cohorts (33.7 vs
45.4 days/cm), with a standardized mean difference of
Table 2 Specific Outcome Measures





in days/cm (± SD)





Salem and Schmelz, 2014 [43] Stimulated 12 7.9 (− to -) 33 (± −) NR NR
Control 9 7.9 (− to -) 45 (± −) NR NR
El-Mowafi and Mohsen, 2005 [41] Stimulated 10 6.1 (5 to 8) 30 (±2.96) NR NR
Control 10 6.1 (5 to 8) 48 (±9.76) NR NR
Dudda et al., 2011 [40] Stimulated 16 6.6 (2.5 to 14.0) 32.8 (±13.1) NR NR
Control 20 6.6 (2.5 to 14.0) 44.4 (±6.8) NR NR
Gebauer and Correll, 2005 [42] Stimulated 17 7.06 (2.5 to 14.0) N = 7, calcification after 6 weeks; N= 10, bridging observed after 12 weeks.
Gonzalez et al., 2005 [44] Stimulated 30 11.3 (5.3 - 15.3) NR 308.3 (±62.82) 279.6 (±68.4)
Control 30 11.3 (53 to 153) NR 339.5 (±61.17) 313.5 (±60.6)
Eyres et al., 1996 [45] Stimulated 10 7.6 (− to -) 39 (±4) NR NR
Control 8 7.6 (− to -) 44 (±6) NR NR
Gold and Wasserman, 2005 [46] Stimulated 8 10.25 (8 to 14) NR 417.3 (± −) NR
Control 12 9.46 (4 to 20) NR 501.3 (± −) NR
NR Not Reported
Table 3 Type of fixator, indications for lengthening, and complications
Indications for Lengthening (number)




Congenital LLD Symmetric Growth
Restrictions
Other LLD Complications
Salem and Schmelz, 2014 [43] Circular 0 21 0 0 0 NR
El-Mowafi and Mohsen, 2005 [41] Circular 0 18 Congenital Anterolateral
Bowing of Tibia (2)
0 0 4 delayed unions,
1 failure to
consolidate
Dudda et al., 2011 [40] Monolateral (23),
Circular (6),
hybrid (7)
0 NR NR NR NR 2 amputations
(infection), 4
Pseudoarthroses













Eyres et al., 1996 [45] Monolateral (16),
Circular (2)
0 0 Congenital short femur









Gold and Wasserman, 2005 [46] Circular 8 0 0 0 0 NR
NR Not Reported
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1.16 (95 % Confidence Intervals of 0.40 to 1.91; p =
0.003), favoring a better healing index within the stimu-
lation cohort when compared to the control cohorts
(Fig. 2). Of the studies that did not provide sufficient
data to incorporate into the analysis, Gonzalez et al. [44]
reported a shorter time to fixator removal (308.3 vs.
339.5 days), shorter time to corticalization (279.6 vs.
313.5 days), increased callus thickness (31.2 vs.
21.8 mm), increased cortical thickness (2.73 vs.
2.63 mm), and increased bone callus density (85.7 vs.
69.8 g/cm3) in limbs stimulated with PEMF compared to
those that were not. Similarly, Gold and Wasserman
[46] found a decreased time in external fixation frame
(13.91 vs. 16.71 months) and a decreased external fix-
ation index (time in frame per cm bone transported of
1.34 vs. 2.02; Table 2). Gebauer and Correll [42] did not
utilize a control group but demonstrated that LIPUS can
successfully salvage delayed unions or non-unions fol-
lowing limb lengthening (DO).
Discussion
Although limb lengthening has been successfully utilized
to treat leg length discrepancies or short stature, the
procedure is not without its inherent risks and compli-
cations [15]. Of these, many are related to slower bone
healing or even non-unions. There has been a recent in-
crease in the popularity of LIPUS in the fracture/non-
union setting, and a recent meta–analysis by Rutten et
al. [49] described that LIPUS was able to reduce the time
to radiographic fracture healing. Similarly, in the setting
of limb lengthening we found that both LIPUS and
PEMF improved the healing index and decreased the
amount of time needed to consolidate regenerate bone
and remain in fixation. Time in fixation has been sug-
gested to be a predictor of complications in these proce-
dures [15]; thus, the use of LIPUS or PEMF may reduce
the incidence of associated complications. It is important
to note that while LIPUS and PEMF have now been
demonstrated to be efficacious in both fracture healing
and DO, these two processes of bone healing differ in
several key ways. While fracture healing and DO both
employ intramembranous and endochondral bone for-
mation, in fracture healing endochondral bone forma-
tion is the primary method of ossification, while in
DO, intramembranous ossification predominates [50,
51]. In comparable times post-injury, DO exhibits
large amounts of unmineralized osteoid in the central
region of the distraction gap, while fracture callus has
already calcified. During fracture healing the process
of angiogenesis is initiated between days 7 and 14
while in DO, angiogenesis only occurs only after ac-
tive distraction commences. There are also molecular
differences between the two processes: in fracture
healing, IL-1, IL-6, and TNF-α are elevated soon after
injury, compared to DO in which only IL-1 and IL-6
become significantly elevated [52].
There were several limitations in this study. Due to
the low frequency of limb lengthening procedures, and
the even rarer number of studies that have evaluated the
stimulation of the regenerate bone, the overall size of
the analyzed cohort is small. In addition, the studies that
were included in our analysis exhibited heterogeneity in
terms of mean patient age, indication for lengthening
(congenital condition vs. trauma), type of bone length-
ened, method of lengthening, as well as the reported
outcome parameters. Hence, the overall reproducibility
of our results may be limited. However, this is the first
study that has comprehensively evaluated both LIPUS
and PEMF to stimulate bone formation following limb
lengthening. In addition, although we found a signifi-
cantly faster healing time, this may not necessarily apply
to the clinical and patient reported outcome measures,
which require further study. Also, certain studies in-
cluded in the analysis were unblinded trials, which may
have introduced bias into the results, however, these
studies did not receive funding from either party. While
there was insufficient data to generate a funnel plot,
sources of funding and competing interests for each in-
dividual study were carefully reviewed to assess for pos-
sible bias. Only one study reported a possible conflict of
interest as the senior author is a consultant for the
Exogen manufacturer; however, the authors received
nothing of value [42].
The adjuvant properties of LIPUS and PEMF for bone
healing have been known for several years. One of the
first studies that evaluated regenerate bone stimulation
Fig. 2 Forest-plot demonstrating the healing index between both
cohorts. Forest-plot showing the effects of LIPUS or PEMF treatment
on mean healing index. Each square represents the size of the study
while bars represent confidence intervals. The diamond at the bottom
of the graph shows the average effect size with a random effect model
of the four studies; the lateral tips of the diamond represent the
associated confidence interval. Note that a standardized mean
difference lower than zero (0), favors stimulation (less time for
bone healing)
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in animals was described by Pilla et al. [53], who
assessed the regenerative properties of LIPUS in frac-
tured rabbit fibulae (n = 139 rabbits). They found that
LIPUS-stimulated fibulae exhibited a biomechanical
healing rate 1.7 times faster than that of unstimulated
fibulae. Fredericks et al. [35] found that following DO,
PEMF-stimulated rabbit tibiae exhibited higher mean
torque-to-fracture values compared with unstimulated tib-
iae. Several other studies have evaluated the potentially
beneficial effects of LIPUS and PEMF on fracture healing
[54–59]. Heckman et al. [55] demonstrated a statistically
significant decrease in the healing time of fractured tibiae
treated with LIPUS as compared to untreated tibiae, while
Sharrard [57] showed that PEMF stimulation of delayed
unions contributed to better outcomes in stimulated tibiae
compared with unstimulated tibiae.
There are also invasive alternatives that could be used
to stimulate the regenerate bone, either in place of or in
conjunction with the previously mentioned modalities. A
study by Lee et al. [27] demonstrated that bone marrow
aspirate combined with platelet rich plasma (PRP) injec-
tion following DO led to a significant improvement in
the mean cortical healing indices as compared to an un-
treated cohort (p < 0.001). Similarly, Kitoh [25] showed
that transplanted bone marrow cells along with PRP
improved average healing indices of patients treated for
short stature or LLD as compared to an untreated
cohort (p = 0.0019 and p = 0.0031, respectively). These
modalities have also been studied in several animal stud-
ies with successful outcomes; however, more prospective,
randomized controlled trials are needed to clarify their
effects [26, 28–30].
Conclusion
Though limited by the inadequate number of studies
and small number of patients in these studies, the results
we obtained and the literature we reviewed support the
use of LIPUS or PEMF following DO. The use of either
modality improves regenerate bone formation and de-
creases the healing time and the amount of time spent
in fixation. This may prevent complications such as de-
layed union, nonunion, or malunion, as well as decrease
the morbidity associated with prolonged external fix-
ation. At the current time however, the use of ultra-
sound is largely limited to nonunion cases. The vast
majority of insurances will not reimburse for this modal-
ity unless the patient is 3 months postoperative and the
affected limb remains non-united. Despite these re-
strictions, we believe that surgeons performing limb
lengthening should consider the possibility of utilizing
these non-invasive methods for regenerate bone
stimulation. However, future studies with larger co-
horts are needed to fully evaluate the potential suc-
cess of these modalities.
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